TITLE

Clinical, Epidemiologic, and Molecular Evaluation of a Clonal Outbreak of Methicillin-Resistant Staphylococcus aureus Infection

AUTHOR(S)
Young, Lisa S.; Perdreau-remington, Françoise; Winston, Lisa C.
PUB. DATE
April 2004
SOURCE
Clinical Infectious Diseases;4/15/2004, Vol. 38 Issue 8, p1075
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
San Francisco General Hospital (San Francisco, CA) experienced an overall increase in the recovery of methicillin-resistant Staphylococcus aureus (MRSA) isolates that were shown by pulsed-field gel electrophoresis to have a genotype (genotype A1) that was new to this institution. We performed a case-control study to identify risk factors for acquiring genotype A1 MRSA infection from 1 October 2001 to 19 July 2002. Patients with genotype Al MRSA infection were compared with 2 control groups: MRSA-infected control patients (i.e., patients with infection due to non-genotype A1 MRSA) and non-MRSA infected control patients (i.e., hospitalized patients without MRSA infection). There were 41 case patients infected with genotype A1 MRSA, 99 control patients infected with MRSA, and 41 control patients without MRSA infection. Pneumonia, surgical wound infections, and line infections occurred more frequently among case patients. Intensive care unit exposure and invasive procedures conferred the greatest risk for genotype A1 MRSA infection in multivariate models. Case patients were not associated with increased mortality, after adjusting for age, comorbidities, and intensive care unit exposure. Genotype A1 MRSA caused a large nosocomial outbreak of infection that was associated with distinct risk factors and clinical manifestations.
ACCESSION #
13015096

 

Related Articles

  • ASK THE EXPERT.  // Shape;Sep2010, Vol. 30 Issue 1, p92 

    A question and answer is presented regarding steps that patients can take to protect themselves from getting the bacterial infection methicillin-resistant staphylococcus aureus (MRSA) when they are in the hospital.

  • Screenings for staph are now the law in Illinois.  // Healthcare Purchasing News;Oct2007, Vol. 31 Issue 10, p34 

    The article focuses on a legislation signed by Illinois governor which requires the screening of hospital patients for dangerous drug-resistant staph infections. The new law requires hospitals to test all patients in hospital intensive-care units for methicillin-resistant staphylococcus aureus...

  • Immunopathogenesis of Staphylococcus aureus pulmonary infection. Parker, Dane; Prince, Alice // Seminars in Immunopathology;Jun2012, Vol. 34 Issue 2, p281 

    Staphylococcus aureus is a common human pathogen highly evolved as both a component of the commensal flora and as a major cause of invasive infection. Severe respiratory infection due to staphylococci has been increasing due to the prevalence of more virulent USA300 CA-MRSA strains in the...

  • Staph infection continues to be problem in hospitals.  // Materials Management in Health Care;Sep2005, Vol. 14 Issue 9, p9 

    Reports on the problem of Staphylococcus aureus infection in hospitals in the U.S. Total number of annual death caused by the disease; Possible methods that can be used to prevent further infection; Inability of hospitals to measure mortality rate occurring after hospital stay.

  • Cleaning up their act? Ward, Seamus // Public Finance;3/25/2005, p20 

    Reports on the fear of medical practitioners on the spread of methicilin-resistant Staphylococcus aureus (MRSA) superbug into the hearts of hospital patient in Great Britain. Victory of the National Health Service over its battle against the drug-resistant bacterium; Description of the...

  • Beat the bug. Boyce, Nell // New Scientist;06/05/99, Vol. 162 Issue 2189, p11 

    Reports on a vaccine that may fight the Staphylococcus aureus virus that causes dangerous infections in hospital patients. Resilience of the virus; Technique used by Gerald Pier at Harvard Medical School to produce the vaccine; Future trials and uses for the vaccine.

  • Substantial cost burden of inpatient staphylococcal infection.  // PharmacoEconomics & Outcomes News;9/24/2005, Issue 487, p8 

    Discusses research being done on Staphylococcus aureus infections on hospitals in the U.S. Reference to a study conducted by G. A. Noskin, R. J. Rubin, J. J. Schentag, J. Kluytmans, E. C. Hedblom, M. Smulders, E. Lapetina and E. Gemmen, published in the August 2005 issue of the "Archives of...

  • Respiratory Viral Infections in Patients With COPD Exacerbation. Hosseini, Seyedeh Somayeh; Jamaati, Hamidreza; Roodbari, Fatemeh; Emamzadegan, Behzad // HealthMed;2012, Vol. 6 Issue 2, p360 

    Background: There is growing evidence that viral infections play a role as a risk factor for COPD exacerbation. This study aimed at epidemiological evaluation of viral respiratory infections in patients COPD exacerbation. Materials and Methods: In this descriptive cross-sectional study...

  • Favorable outcome of pneumonia due to Panton–Valentine leukocidin-producing Staphylococcus aureus associated with hematogenous origin and absence of flu-like illness. Alonso-Tarrés, C.; Villegas, M. L.; de Gispert, F. J.; Cortés-Lletget, M. C.; Plarromaní, A. Rovira; Etienne, J. // European Journal of Clinical Microbiology & Infectious Diseases;Nov2005, Vol. 24 Issue 11, p756 

    Reported here is what is believed to be the first case of community-acquired pneumonia caused by a Panton–Valentine leukocidin-producing strain of Staphylococcus aureus in Spain. Although lung infections caused by S. aureus strains carrying this powerful leukocidin gene are associated...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics